Techne Corp., which makes products for the research and diagnostic markets, is buying U.K.-based Tocris for $124 million. ... Techne Corp. buys Tocris Holdings Ltd. for $124 million ...

Bio-Techne will host an earnings conference call today, February 5, 2025, at 8:00 a.m. CST. To listen, please dial 1-877-407-9208 or 1-201-493-6784 (for international callers), and reference ...

Shares of Bio-Techne (NASDAQ:TECH) traded sharply lower in the early premarket trading on Wednesday after KeyBanc Capital Markets downgraded the stock, arguing that the life sciences firm is ...

View Bio-Techne Corporation TECH stock quote prices, financial information, real-time forecasts, and company news from CNN.

Asset Management One Co. Ltd. lifted its stake in Bio-Techne Corp (NASDAQ:TECH - Free Report) by 12.8% during the first ...

Bio-Techne on Wednesday beat Wall Street estimates for third-quarter profit, driven by growth in its unit that provides proteins, antibodies and other products for research and said it is ...

In previous years, Bio-Techne has received weak shareholder support for the executive compensation plan. Last year, 62% of shareholders supported the plan, and the year before only 55% cast yes votes.

Bio-Techne passes $1B in annual sales, plans for exit of CEO in 2024. Chuck Kummeth, who has led the Minneapolis-based life science firm since 2013, will step down in two years.

GAAP Earnings Results. GAAP EPS was $0.14 per diluted share, versus $0.31 in the same quarter last year. GAAP operating income for the third quarter of fiscal 2025 decreased 42% to $38.7 million ...